G. Kurzawski

发表

CHEK2 is a multiorgan cancer susceptibility gene.

J. Lubiński, S. Narod, E. Grabowska, 2004, American journal of human genetics.

Germline 657del5 mutation in the NBS1 gene in breast cancer patients

Maria Chosia, Rodney Scott, Anna Jakubowska, 2003, International journal of cancer.

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families

R. Scott, J. Lubiński, C. Cybulski, 2015, Hereditary cancer in clinical practice.

A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants

R. Scott, G. Capellá, J. Lubiński, 2021, Scientific Reports.

Combined analysis of three lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers

P. Møller, R. Scott, J. Lubiński, 2013, International journal of cancer.

Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer

R. Scott, J. Lubiński, T. Grodzki, 2005, Breast Cancer Research and Treatment.

Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin

J. Kładny, A. Jakubowska, J. Lubiński, 2003, Melanoma research.

Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation

J. Kładny, A. Jakubowska, C. Cybulski, 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

J. Lubiński, J. Raszeja-Wyszomirska, G. Kurzawski, 2010, World journal of gastroenterology.

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility

J. Kładny, R. Scott, J. Lubiński, 2010, BMC Cancer.

Clinical, Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in Latvia

B. Górski, Janina Suchy, Andrejs Vanags, 2005, Hereditary cancer in clinical practice.

Hereditary Colorectal Cancer (CRC) Program in Latvia

B. Górski, Janina Suchy, J. Gardovskis, 2003 .

Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography.

R. Scott, J. Lubiński, K. Safranow, 2002, Journal of biochemical and biophysical methods.

Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome

R. Scott, J. Lubiński, A. Spigelman, 2010, Journal of Medical Genetics.

The 3020insC allele of NOD2 predisposes to early-onset breast cancer

J. Lubiński, S. Narod, T. Byrski, 2004, Breast Cancer Research and Treatment.

Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age

Daniel M. Johnstone, J. Lubiński, A. Spigelman, 2009, International journal of cancer.

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients

J. Lubiński, M. Droździk, M. Kurzawski, 2005, European Journal of Clinical Pharmacology.

CARD15 variants in patients with sporadic Parkinson's disease

G. Opala, E. Tan, M. Droździk, 2007, Neuroscience Research.

Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps.

J. Kładny, J. Lubiński, D. Bielicki, 1999, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism.

J. Kładny, R. Scott, J. Lubiński, 2009, Cancer epidemiology.

Some aspects of molecular diagnostics in Lynch syndrome

G. Kurzawski, 2006, Hereditary cancer in clinical practice.

NOD2 variants and the risk of malignant melanoma

C. Cybulski, T. Byrski, T. Huzarski, 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

The NOD 2 3020 insC Mutation and the Risk of Colorectal Cancer

J. Kładny, R. Scott, A. Jakubowska, 2004 .

Advances in Brief The NOD 2 3020 insC Mutation and the Risk of Colorectal Cancer

J. Kładny, R. Scott, A. Jakubowska, 2004 .

CD36 gene polymorphism and plasma sCD36 as the risk factor in higher cholesterolemia.

K. Safranow, D. Chlubek, B. Garanty-Bogacka, 2018, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

The 3020insC allele of NOD2 predisposes to early-onset breast cancer

J. Lubiński, Micha, S. Narod, 2004, Breast Cancer Research and Treatment.

Frequency and nature of hMSH6 germline mutations in Polish patients with colorectal, endometrial and ovarian cancers

J. Kładny, K. Safranow, G. Kurzawski, 2006, Clinical genetics.

Ovarian cancer of endometrioid type as part of the MSH6 gene mutation phenotype

A. Jakubowska, J. Lubiński, Janina Suchy, 2002, Journal of Human Genetics.

Polymorphism of the CD36 Gene and Cardiovascular Risk Factors in Patients with Coronary Artery Disease Manifested at a Young Age

K. Safranow, D. Chlubek, Janina Suchy, 2011, Biochemical Genetics.

Hereditary Cancer in Clinical Practice 2006; 4(2) pp. 94-102 The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria

R. Scott, J. Lubiński, C. Meldrum, 2006 .

Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer.

J. Kładny, T. Dębniak, B. Górski, 2000, European journal of cancer.

Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool.

J. Kładny, T. Dębniak, G. Kurzawski, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Polymorphism of CD36 gene, carbohydrate metabolism and plasma CD36 concentration in obese children. A preliminary study.

K. Safranow, D. Chlubek, M. Syrenicz, 2012, Postepy higieny i medycyny doswiadczalnej.

Association of MMP8 gene variation with an increased risk of malignant melanoma

A. Jakubowska, J. Lubiński, S. Ye, 2011, Melanoma research.

Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer

R. Scott, J. Lubiński, C. Cybulski, 2004, International journal of cancer.

Novel germline mutations in the adenomatous polyposis coli gene in Polish families with familial adenomatous polyposis

M. Drews, D. Lipiński, A. Pławski, 2004, Journal of Medical Genetics.

CDKN2A common variants and their association with melanoma risk: a population-based study.

J. Kładny, R. Scott, J. Lubiński, 2005, Cancer research.

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

J. Kładny, J. Lubiński, S. Narod, 2007, European Journal of Human Genetics.

Nuclear Pedigree Criteria of Suspected HNPCC

J. Kładny, A. Jakubowska, J. Lubiński, 2003, Hereditary Cancer in Clinical Practice.

Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States

J. Kładny, A. Jakubowska, K. Safranow, 2002, Journal of medical genetics.

IGF1 is a modifier of disease risk in hereditary non‐polyposis colorectal cancer

R. Scott, J. Lubiński, C. Meldrum, 2008, International journal of cancer.

Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population

J. Kładny, R. Scott, J. Lubiński, 2014, Molecular Biology Reports.

Relationship between acetylation polymorphism and risk of atopic diseases

G. Kurzawski, B. Gawrońska-Szklarz, G. Czaja-Bulsa, 1999, Clinical pharmacology and therapeutics.

Frequency of mutations related to hereditary haemochromatosis in northwestern Poland

J. Lubiński, J. Raszeja-Wyszomirska, P. Milkiewicz, 2008, Journal of Applied Genetics.

CDKN 2 A Common Variants and Their Association with Melanoma Risk : A Population-Based Study

J. Kładny, R. Scott, J. Lubiński, 2005 .

CDKN2A common variant and multi‐organ cancer risk—a population‐based study

R. Scott, J. Lubiński, S. Narod, 2006, International journal of cancer.

CDKN 2 A common variant and multi-organ cancer risk — a population-based study

R. Scott, J. Lubiński, S. Narod, 2006 .

SHORT REPORT CDKN2A common variant and multi-organ cancer risk—a population-based study

R. Scott, J. Lubiński, S. Narod, 2006 .

Aurora‐A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer

R. Scott, J. Lubiński, C. Meldrum, 2008, International journal of cancer.

Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro.

P. Jagodziński, T. Uryu, H. Nakashima, 1994, Virology.

Comparison of Alu-PCR, microsatellite instability, and immunohistochemical analyses in finding features characteristic for hereditary nonpolyposis colorectal cancer

J. Kładny, A. Jakubowska, J. Lubiński, 2001, Journal of Cancer Research and Clinical Oncology.

New EPCAM founder deletion in Polish population

A. Pławski, T. Byrski, T. Huzarski, 2017, Clinical genetics.

DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.

R. Scott, J. Lubiński, A. Spigelman, 2012, Cancer epidemiology.

DNA and RNA analyses in detection of genetic predisposition to cancer

R. Scott, A. Jakubowska, J. Trubicka, 2008, Hereditary Cancer in Clinical Practice.

The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs

A. Jakubowska, J. Lubiński, S. Narod, 2005 .

Molecular basis of inherited predispositions for tumors.

A. Jakubowska, J. Lubiński, E. Grabowska, 2002, Acta biochimica Polonica.

Molecular Analyses in Diagnosis of High Genetic Predispositions to Malignancies

J. Kładny, A. Jakubowska, J. Lubiński, 2000 .

Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review

J. Lubiński, G. Kurzawski, K. Tutlewska, 2013, Hereditary cancer in clinical practice.

Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin

J. Kładny, J. Lubiński, C. Cybulski, 2004, Melanoma research.

CHEK2 mutations and HNPCC‐related colorectal cancer

J. Kładny, A. Jakubowska, J. Lubiński, 2010, International journal of cancer.

A novel founder CHEK2 mutation is associated with increased prostate cancer risk.

J. Lubiński, R. Czajka, S. Narod, 2004, Cancer research.

Advances in Brief A Novel Founder CHEK 2 Mutation is Associated with Increased Prostate Cancer Risk

J. Lubiński, R. Czajka, S. Narod, 2004 .

A Novel Founder CHEK 2 Mutation is Associated with Increased Prostate Cancer Risk

R. Czajka, S. Narod, C. Cybulski, 2004 .

Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study)

J. Kładny, A. Jakubowska, K. Safranow, 2005, Clinical genetics.

Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk

Rodney J Scott, Grzegorz Kurzawski, Janina Suchy, 2008, BMC Cancer.

Cumulative effects of genetic markers and the detection of advanced colorectal neoplasias by population screening

J. Lubiński, E. Małecka-Panas, T. Dębniak, 2015, Clinical genetics.

Cumulative Small Effect Genetic Markers and the Risk of Colorectal Cancer in Poland, Estonia, Lithuania, and Latvia

R. Scott, A. Metspalu, J. Lubiński, 2015, Gastroenterology research and practice.

Frequency and nature of germline Rb-1 gene mutations in a series of patients with sporadic unilateral retinoblastoma.

A. Jakubowska, J. Lubiński, B. Górski, 1999, European journal of cancer.

Age at diagnosis to discriminate those patients for whom constitutional DNA sequencing is appropriate in sporadic unilateral retinoblastoma.

A. Jakubowska, G. Kurzawski, J. Lubiński, 1998, European Journal of Cancer.

DNA testing for variants conferring low or moderate increase in the risk of cancer

J. Lubiński, C. Cybulski, T. Huzarski, 2008, Hereditary cancer in clinical practice.

MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk

J. Kładny, R. Scott, J. Lubiński, 2006, International journal of cancer.

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

R. Scott, A. Jakubowska, J. Lubiński, 2006, Hereditary cancer in clinical practice.

Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene

A. Jakubowska, J. Lubiński, L. Sagan, 2002, Journal of medical genetics.

Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations

K. Huebner, J. Lubiński, P. Rabbitts, 1996, Virchows Archiv.

Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population

J. Kładny, R. Scott, J. Lubiński, 2014, Molecular Biology Reports.

Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients?

K. Safranow, D. Chlubek, V. Dziedziejko, 2015, Scandinavian journal of clinical and laboratory investigation.

The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer.

J. Lubiński, C. Meldrum, Janina Suchy, 2008, Cancer letters.

Is CD36 gene polymorphism in region encoding lipid-binding domain associated with early onset CAD?

K. Safranow, D. Chlubek, G. Kurzawski, 2013, Gene.

Optimization of experimental conditions for RNA‐based sequencing of MLH1 and MSH2 genes

J. Kładny, R. Scott, A. Jakubowska, 2001, Human mutation.

Electro-Oculographic and Electroretinographic Studies in HNPCC Gene Mutation Carriers

R. Scott, J. Lubiński, W. Lubiński, 2003, Ophthalmic Research.

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families

R. Scott, J. Lubiński, C. Cybulski, 2015, Hereditary cancer in clinical practice.

Lynch syndrome mutations shared by the Baltic States and Poland

J. Kładny, A. Metspalu, T. Byrski, 2014, Clinical genetics.

Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.

B. Górski, Janina Suchy, J. Gardovskis, 2007, Anticancer research.

Polymorphism of the CD36 Gene and Cardiovascular Risk Factors in Patients with Coronary Artery Disease Manifested at a Young Age

K. Safranow, D. Chlubek, Janina Suchy, 2011, Biochemical Genetics.

BRCA1 mutations and colorectal cancer in Poland

Anna Jakubowska, Rafał Wiśniowski, Tadeusz Dębniak, 2010, Familial Cancer.

Analysis of γδ+ T cells in peripheral blood of children with perinatal human immunodeficiency virus (HIV) infection

D. Kozbor, E. Hyjek, G. Kurzawski, 1993, Journal of Clinical Immunology.

The NOD2 3020insC Mutation and the Risk of Colorectal Cancer

Rodney J Scott, Anna Jakubowska, Grzegorz Kurzawski, 2004, Cancer Research.

MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer

J. Lubiński, A. Spigelman, P. McElduff, 2009, European Journal of Human Genetics.

AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases

K. Safranow, D. Chlubek, Z. Kornacewicz-Jach, 2010, Journal of Applied Genetics.

Association of CD36 gene polymorphisms with echo- and electrocardiographic parameters in patients with early onset coronary artery disease

K. Safranow, D. Chlubek, G. Kurzawski, 2012, Archives of medical science : AMS.

Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene

S. Richard, C. Cybulski, E. Maher, 1999, Human Genetics.

HFE gene mutations in patients with alcoholic liver disease. A prospective study from northwestern Poland.

J. Lubiński, J. Raszeja-Wyszomirska, P. Milkiewicz, 2010, Polskie Archiwum Medycyny Wewnetrznej.

Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients

J. Kładny, J. Lubiński, R. Słomski, 2011, The Journal of molecular diagnostics : JMD.

DNA and RNA analyses in detection of genetic predisposition to cancer.

B. Masojć, G. Kurzawski, Joanna Matyjasik, 2008, Hereditary Cancer in Clinical Practice.

Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)

T. Dębniak, G. Kurzawski, J. Suchy, 2012, Hereditary Cancer in Clinical Practice.

MSH2 and MLH1 testing

J. Lubiński, Janina Suchy, G. Kurzawski, 2008, Hereditary Cancer in Clinical Practice.

Age at diagnosis of cancer as predictor of mutation occurrence in families suspected of HNPCC.

J. Kładny, T. Dębniak, G. Kurzawski, 2001, Journal of applied genetics.

Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)

T. Dębniak, G. Kurzawski, J. Suchy, 2012, Hereditary Cancer in Clinical Practice.

Analysis of human CD36 gene sequence alterations in the oxidized low-density lipoprotein-binding region using denaturing high-performance liquid chromatography.

K. Safranow, D. Chlubek, B. Garanty-Bogacka, 2010, Genetic testing and molecular biomarkers.

A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants

G. Capellá, J. Lubiński, B. Talseth-Palmer, 2021, Scientific Reports.

Lynch syndrome (HNPCC)

J. Kładny, J. Lubiński, T. Dębniak, 2015 .

Fluorescence in situ detection of human cutaneous melanoma: study of diagnostic parameters of the method.

W. Ruka, G. Kurzawski, B W Chwirot, 2001, The Journal of investigative dermatology.

Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism.

J. Kładny, J. Lubiński, Janina Suchy, 2009, Cancer epidemiology.